Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31Also trades as ACCH
$0.13−0.02 (-13.33%)
Close on Nov 13, 2026Market cap $10.00MP/E –Yield –
Accendra Health gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Accendra Health's gross profit for the twelve months ending Sep 30, 2026 was $1.13B, down 35.8% year over year. For fiscal 2025 it was $1.29B, down 41.9% from the year before. Over ten years it grew 0.6% a year on average. The highest annual figure on record is $2.22B in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29B | -41.9% |
| FY2024 | Dec 31, 2024 | $2.22B | +4.4% |
| FY2023 | Dec 31, 2023 | $2.13B | +16.4% |
| FY2022 | Dec 31, 2022 | $1.83B | +20.7% |
| FY2021 | Dec 31, 2021 | $1.51B | +18.1% |
| FY2020 | Dec 31, 2020 | $1.28B | +13.5% |
| FY2019 | Dec 31, 2019 | $1.13B | +5.4% |
| FY2018 | Dec 31, 2018 | $1.07B | -8.6% |
| FY2017 | Dec 31, 2017 | $1.17B | -1.3% |
| FY2016 | Dec 31, 2016 | $1.19B | -2.2% |
| FY2015 | Dec 31, 2015 | $1.21B | +3.8% |
| FY2014 | Dec 31, 2014 | $1.17B | +4.7% |
| FY2013 | Dec 31, 2013 | $1.12B | +20.8% |
| FY2012 | Dec 31, 2012 | $924.65M | +7.8% |
| FY2011 | Dec 31, 2011 | $857.54M | +6.2% |
| FY2010 | Dec 31, 2010 | $807.73M | -0.8% |
| FY2009 | Dec 31, 2009 | $814.39M | +9.9% |
| FY2008 | Dec 31, 2008 | $741.11M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $261.31M | -18.9% |
| Q2 FY2026 | Jun 30, 2026 | $263.41M | -18.9% |
| Q1 FY2026 | Mar 31, 2026 | $278.03M | -47.1% |
| Q4 FY2025 | Dec 31, 2025 | $323.26M | -44.2% |
| Q3 FY2025 | Sep 30, 2025 | $322.20M | -42.4% |
| Q2 FY2025 | Jun 30, 2025 | $324.60M | -40.3% |
| Q1 FY2025 | Mar 31, 2025 | $526.01M | -1.8% |
| Q4 FY2024 | Dec 31, 2024 | $579.77M | +1.7% |
| Q3 FY2024 | Sep 30, 2024 | $559.71M | +3.9% |
| Q2 FY2024 | Jun 30, 2024 | $544.15M | +4.8% |
| Q1 FY2024 | Mar 31, 2024 | $535.53M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $569.92M | +40.0% |
| Q3 FY2023 | Sep 30, 2023 | $538.50M | +4.9% |
| Q2 FY2023 | Jun 30, 2023 | $519.43M | -2.5% |
| Q1 FY2023 | Mar 31, 2023 | $497.31M | +33.2% |
| Q4 FY2022 | Dec 31, 2022 | $407.12M | +19.2% |
| Q3 FY2022 | Sep 30, 2022 | $513.28M | +56.1% |
| Q2 FY2022 | Jun 30, 2022 | $532.51M | +33.1% |
| Q1 FY2022 | Mar 31, 2022 | $373.45M | -15.7% |
| Q4 FY2021 | Dec 31, 2021 | $341.57M | -14.3% |
| Q3 FY2021 | Sep 30, 2021 | $328.84M | -4.5% |
| Q2 FY2021 | Jun 30, 2021 | $400.07M | +48.5% |
| Q1 FY2021 | Mar 31, 2021 | $442.75M | +64.9% |
| Q4 FY2020 | Dec 31, 2020 | $398.53M | +40.0% |
| Q3 FY2020 | Sep 30, 2020 | $344.34M | +22.7% |
| Q2 FY2020 | Jun 30, 2020 | $269.41M | -6.0% |
| Q1 FY2020 | Mar 31, 2020 | $268.56M | -2.9% |
| Q4 FY2019 | Dec 31, 2019 | $284.73M | +317.0% |
| Q3 FY2019 | Sep 30, 2019 | $280.62M | -20.4% |
| Q2 FY2019 | Jun 30, 2019 | $286.52M | -11.8% |
| Q1 FY2019 | Mar 31, 2019 | $276.62M | -14.8% |
| Q4 FY2018 | Dec 31, 2018 | $68.27M | -78.3% |
| Q3 FY2018 | Sep 30, 2018 | $352.57M | +16.8% |
| Q2 FY2018 | Jun 30, 2018 | $324.99M | +18.8% |
| Q1 FY2018 | Mar 31, 2018 | $324.69M | +15.5% |
| Q4 FY2017 | Dec 31, 2017 | $315.21M | +6.9% |
| Q3 FY2017 | Sep 30, 2017 | $301.94M | – |
| Q2 FY2017 | Jun 30, 2017 | $273.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $281.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $294.98M | – |
See a number that looks wrong?